Renal Cancer - Results from #860

Changes in Perception of Cure Among Patients With Genitourinary Cancers Initiating Immune Checkpoint Inhibitors: A Longitudinal Study. July 6, 2023

Techniques and outcomes of percutaneous tumour ablation for small renal masses. July 6, 2023

Comparison and validation of different risk models for papillary renal cell carcinoma. July 5, 2023

The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies. July 5, 2023

Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma. July 4, 2023

Combination of Sarcopenia and Hypoalbuminemia Is a Poor Prognostic Factor in Surgically Treated Nonmetastatic Renal Cell Carcinoma. July 4, 2023

Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study. July 2, 2023

Efficacy and safety of MWA versus RFA and CA for renal tumors: A systematic review and meta-analysis of comparison studies. July 2, 2023

A self-supervised vision transformer to predict survival from histopathology in renal cell carcinoma. June 30, 2023

Complications after Nephron-sparing Interventions for Renal Tumors: Imaging Findings and Management. June 30, 2023

A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma. June 29, 2023

Clinical Performance of Technetium-99m-Sestamibi SPECT/CT Imaging in Differentiating Oncocytic Tumors from Renal Cell Carcinoma in Routine Clinical Practice. June 29, 2023

Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive Nephrectomy. June 28, 2023

Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy. June 28, 2023

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma. June 28, 2023

FN1 and cancer-associated fibroblasts markers influence immune microenvironment in clear cell renal cell carcinoma. June 27, 2023

Concordance of MTOR Pathway Mutations and the Diagnosis of Renal Low-Grade Oncocytic Tumor (LOT). June 27, 2023

Renal Neoplasia Occurring in Patients With PTEN Hamartoma Tumor Syndrome: Clinicopathologic Study of 12 Renal Cell Carcinomas From 9 Patients and Association With Intrarenal "Lipomas". June 27, 2023

Analysis of clinical characteristics and prognostic factors of elderly patients with renal cell carcinoma based on the SEER database. June 26, 2023

Managing Metastatic Renal Cell Carcinoma after Progression on Immunotherapy. June 26, 2023

Page 44 of 456